首页> 外文期刊>Annals of tropical medicine and parasitology >Efficacy of albendazole and its combinations with ivermectin or diethylcarbamazine (DEC) in the treatment of Trichuris trichiura infections in Sri Lanka.
【24h】

Efficacy of albendazole and its combinations with ivermectin or diethylcarbamazine (DEC) in the treatment of Trichuris trichiura infections in Sri Lanka.

机译:阿苯达唑及其与伊维菌素或二乙基卡巴嗪(DEC)的组合在斯里兰卡治疗Trichuris trichiura感染中的功效。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The efficacy of the drugs currently available for treatment of infection with Trichuris trichiura is low compared with that of the drugs used against roundworm and hookworm. Single-dose combinations of albendazole with ivermectin or of albendazole with diethylcarbamazine (DEC) have recently been seen to produce raid and sustained reductions in Wuchereria bancrofti microfilaraemia. This observation prompted the present study, on the efficacy of these combinations against trichuriasis. The drug regimens tested were albendazole (400 mg) alone, albendazole (400 mg) with ivermectin (200 micrograms/kg), and albendazole (400 mg) with DEC (6 mg/kg). Most (155) of the 176 children (4-14 years of age) who each provided a single, pre-treatment, stool sample were found positive for Trichuris ova. These 155 were each randomly allocated to one of the three treatment groups and checked for infection 3 weeks post-treatment, again by a single stool examination. Single-dose therapy with albendazole plus ivermectin produced a 'cure rate' (79.3%) and an egg-reduction rate (93.8%) which were significantly higher than the corresponding rates produced by albendazole alone or albendazole plus DEC (P < 0.01 for each). The efficacies of albendazole with DEC and of albendazole alone were statistically equivalent. Single-dose treatment with the albendazole-ivermectin combination appears to be highly effective against trichuriasis and could prove valuable for routine use.
机译:与对抗round虫和钩虫的药物相比,目前可用于治疗Trichuris trichiura感染的药物的功效较低。最近已发现阿苯达唑与伊维菌素的单剂量组合或阿苯达唑与二乙基氨基甲嗪(DEC)的单剂量组合可突袭并持续减少班氏无草菌微丝蛋白血症。这种观察促使本研究对这些组合抗滴虫病的功效进行了研究。测试的药物方案为单独的阿苯达唑(400 mg),具有伊维菌素(200μg/ kg)的阿苯达唑(400 mg)和具有DEC(6 mg / kg)的阿苯达唑(400 mg)。 176名儿童(4-14岁)中的大多数(155名)每个人都提供了一个单独的,治疗前的粪便样品,发现他们的Trichuris ova呈阳性。将这155个随机分配到三个治疗组之一,并在治疗后3周检查一次感染,再次通过一次粪便检查。阿苯达唑加伊维菌素的单剂量治疗的“治愈率”(79.3%)和减蛋率(93.8%)显着高于单独使用阿苯达唑或阿苯达唑加DEC的相应治愈率(每个P <0.01) )。阿苯达唑与DEC的疗效以及仅阿苯达唑的疗效在统计学上均等。阿苯达唑-伊维菌素联合用药的单剂量治疗对付滴虫病似乎非常有效,对常规使用可能证明是有价值的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号